CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.34, 2016 (SCI İndekslerine Giren Dergi)
Objective. To date, no biomarker is universally accepted to be a surrogate for active disease being one of major difficulties in follow-up of Takayasu's arteritis (TAK). In this study, we aimed to investigate plasma pentraxin-3 (PTX-3) levels and its correlation with activity in patients with TAK.